★ WIDE MOAT STOCKS & COMPETITIVE ADVANTAGES ★
VOL. XCIV, NO. 247
Stock Profile
HCA Healthcare, Inc. (HCA) Moat Analysis
HCA Healthcare, Inc.
HCA · New York Stock Exchange
Weighted average of segment moat scores, combining moat strength, durability, confidence, market structure, pricing power, and market share.
Request update
Spot something outdated? Send a quick note and source so we can refresh this profile.
Overview
HCA Healthcare operates a large acute-care hospital and outpatient footprint across 19 U.S. states and England. At March 31, 2026, it operated 189 hospitals, 119 freestanding surgery centers and 30 freestanding endoscopy centers; Q1 2026 revenue rose 4.3% to $19.1B. The moat stems from regulatory and permitting barriers in certain states, dense local facility networks that are hard to replicate quickly, and scale-driven shared services, purchasing and staffing systems that can improve unit economics. Counterforces include payer consolidation and narrow/tiered networks, labor cost pressure, government reimbursement limits, and site-of-care shifts toward lower-cost outpatient settings.
Primary segment
Hospitals and related healthcare entities
Market structure
Oligopoly
Market share
—
HHI: —
Coverage
1 segments · 6 tags
Updated 2026-07-12
Segments
Hospitals and related healthcare entities
Acute care hospitals and outpatient healthcare services
Revenue
100%
Structure
Oligopoly
Pricing
moderate
Share
—
Peers
Moat Claims
Hospitals and related healthcare entities
Acute care hospitals and outpatient healthcare services
HCA reports operating hospitals and related healthcare entities as its core line of business. At 2026-03-31 it operated 189 hospitals, 119 freestanding surgery centers and 30 freestanding endoscopy centers in 19 states and England. Q1 2026 same-facility revenues increased 4.5%, driven by 1.3% same-facility equivalent-admission growth and 3.1% same-facility revenue per equivalent admission.
Permits Rights Of Way
Legal
Permits Rights Of Way
Strength
Durability
Confidence
Evidence
In many states, hospital/facility expansion and certain service-line additions face licensing and certificate-of-need style approvals, slowing entrants and capacity additions.
Permits Rights Of Way moat: definition, examples, and stocks
Erosion risks
- CON deregulation or higher thresholds for review
- Care shifting to less-regulated outpatient settings
Leading indicators
- State-level CON reform bills / regulatory changes
- Competitor announcements of new hospitals or major bed expansions
Counterarguments
- Many states have limited or no CON requirements, enabling new entrants
- Outpatient-focused competitors can grow without building full hospitals
Scope Economies
Supply
Scope Economies
Strength
Durability
Confidence
Evidence
Large multi-market footprint supports centralized shared services (revenue cycle, purchasing, supply chain, staffing) that can lower unit costs and improve operational execution versus smaller systems.
Scope Economies moat: definition, examples, and stocks
Erosion risks
- Labor cost inflation and persistent staffing shortages
- Competitors replicating shared-service platforms and standardization
- Supplier price shocks that overwhelm purchasing leverage
Leading indicators
- Supply expense per adjusted admission
- Contract labor spend trend
- SG&A as a percent of revenue
Counterarguments
- Large nonprofit IDNs can have similar purchasing and shared-service scale in their regions
- Some shared-service advantages are accessible via third-party vendors and group purchasing organizations
Physical Network Density
Supply
Physical Network Density
Strength
Durability
Confidence
Evidence
Dense local footprints (hospitals plus outpatient sites) improve access, referral capture, physician alignment, and make full replacement by a new entrant capital-intensive and slow.
Physical Network Density moat: definition, examples, and stocks
Erosion risks
- Procedure migration to independent ASCs and physician-owned sites
- Telehealth substitution for lower-acuity encounters
- Payer steering to lower-cost competitors
Leading indicators
- Same-facility admissions / ER visits trend
- Outpatient surgery growth versus inpatient mix
- Physician recruitment/retention and affiliation metrics
Counterarguments
- Many services are shoppable; patients can switch providers, especially for elective procedures
- Ambulatory-first competitors can cherry-pick profitable service lines, reducing hospital economics
Evidence
may also have the effect of restricting competition.
Company describes certificate-of-need (CON) laws as potentially restricting competition in certain service areas.
leverage cost-saving practices across our extensive network.
Supports management's stated strategy of using scale/scope plus shared services to manage costs.
owned and operated 189 hospitals, 119 freestanding surgery centers
Demonstrates a large hospital and ambulatory-surgery footprint that is difficult to replicate quickly in local markets.
Revenues increased 4.3 percent to $19.109 billion
Recent operating results support ongoing demand across the network despite outpatient and payer pressures.
Risks & Indicators
Erosion risks
- CON deregulation or higher thresholds for review
- Care shifting to less-regulated outpatient settings
- Labor cost inflation and persistent staffing shortages
- Competitors replicating shared-service platforms and standardization
- Supplier price shocks that overwhelm purchasing leverage
- Procedure migration to independent ASCs and physician-owned sites
Leading indicators
- State-level CON reform bills / regulatory changes
- Competitor announcements of new hospitals or major bed expansions
- Supply expense per adjusted admission
- Contract labor spend trend
- SG&A as a percent of revenue
- Same-facility admissions / ER visits trend
Research HCA elsewhere
Keep the research going
More Rankings & Systems
Quality Stocks
High quality stocks ranked by profitability, margins, free cash flow quality, durability, solvency, and accounting...
Stock rankingUndervalued Stocks
Undervalued stocks from the NA & Europe universe, ranked with a multi-measure value system and quality controls.
Stock rankingDividend Stocks
Dividend stocks ranked by payout yield, payout sustainability, dividend growth, quality, balance-sheet safety, risk...
Stock rankingDefensive Stocks
Defensive stocks ranked by low volatility, low beta, intermediate momentum, durable profitability, balance sheet...
Stock rankingMomentum Stocks
Momentum stocks ranked by total return momentum, relative momentum, trend confirmation, and risk-adjusted momentum...
Stock rankingConviction 10
A concentrated 10-stock strategy from the NA & Europe universe, ranked across quality, value, growth, momentum, and...
Curation & Accuracy
This directory blends AI‑assisted discovery with human curation. Entries are reviewed, edited, and organized with the goal of expanding coverage and sharpening quality over time. Your feedback helps steer improvements (because no single human can capture everything all at once).
Details change. Pricing, features, and availability may be incomplete or out of date. Treat listings as a starting point and verify on the provider’s site before making decisions. If you spot an error or a gap, send a quick note and I’ll adjust.